Glenmark Pharma reports 8% fall in consolidated net profit in Q2

07 Nov 2020 Evaluate

Glenmark Pharmaceuticals has reported results for the second quarter ended September 30, 2020.

The company has reported 6.74% fall in its net profit of Rs 402.88 crore for the quarter under review against net profit of Rs 431.99 crore for the same quarter in the previous year. However, total income of the company increased by 7.23% at Rs 2,125.57 crore for Q2FY21 as compared Rs 1,982.29 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported 8.43% fall in its net profit from continuing operations at Rs 233.99 crore for the quarter under review as compared to net profit at Rs 255.54 crore for the same quarter in the previous year. However, total income of the company marginally increased by 0.85% at Rs 2,920.60 crore for Q2FY21 as compared Rs 2,895.87 crore for the corresponding quarter previous year.

Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×